In 2023, one in 60 adults were prescribed a GLP-1 medication, according to the American Pharmacists Association
From ancient pine bark uses to Pycnogenol
Common adverse effects include nausea, diarrhea, vomiting, constipation, and abdominal pain, which are generally mild to moderate and diminish over time
The global market is projected to register a CAGR of 7.5% during the forecast period, 2023-2032
List of few ongoing clinical trials involving obesity therapies In short, the future of GLP-1 therapy is moving toward greater convenience, higher efficacy, and more individualized care
The blend offers a single injection that covers both mechanisms for patients managing goals across both categories